1. Home
  2. IMUX vs AGAE Comparison

IMUX vs AGAE Comparison

Compare IMUX & AGAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMUX
  • AGAE
  • Stock Information
  • Founded
  • IMUX 2016
  • AGAE 2017
  • Country
  • IMUX United States
  • AGAE United States
  • Employees
  • IMUX N/A
  • AGAE N/A
  • Industry
  • IMUX Biotechnology: Pharmaceutical Preparations
  • AGAE Cable & Other Pay Television Services
  • Sector
  • IMUX Health Care
  • AGAE Telecommunications
  • Exchange
  • IMUX Nasdaq
  • AGAE Nasdaq
  • Market Cap
  • IMUX 90.4M
  • AGAE 73.8M
  • IPO Year
  • IMUX N/A
  • AGAE N/A
  • Fundamental
  • Price
  • IMUX $0.82
  • AGAE $1.11
  • Analyst Decision
  • IMUX Strong Buy
  • AGAE
  • Analyst Count
  • IMUX 5
  • AGAE 0
  • Target Price
  • IMUX $7.50
  • AGAE N/A
  • AVG Volume (30 Days)
  • IMUX 1.4M
  • AGAE 5.9M
  • Earning Date
  • IMUX 11-06-2025
  • AGAE 11-13-2025
  • Dividend Yield
  • IMUX N/A
  • AGAE N/A
  • EPS Growth
  • IMUX N/A
  • AGAE N/A
  • EPS
  • IMUX N/A
  • AGAE N/A
  • Revenue
  • IMUX N/A
  • AGAE $8,254,861.00
  • Revenue This Year
  • IMUX N/A
  • AGAE N/A
  • Revenue Next Year
  • IMUX N/A
  • AGAE N/A
  • P/E Ratio
  • IMUX N/A
  • AGAE N/A
  • Revenue Growth
  • IMUX N/A
  • AGAE 0.52
  • 52 Week Low
  • IMUX $0.56
  • AGAE $0.70
  • 52 Week High
  • IMUX $2.11
  • AGAE $3.79
  • Technical
  • Relative Strength Index (RSI)
  • IMUX 45.68
  • AGAE 44.84
  • Support Level
  • IMUX $0.75
  • AGAE $0.86
  • Resistance Level
  • IMUX $0.90
  • AGAE $2.28
  • Average True Range (ATR)
  • IMUX 0.05
  • AGAE 0.20
  • MACD
  • IMUX -0.00
  • AGAE 0.04
  • Stochastic Oscillator
  • IMUX 47.20
  • AGAE 17.84

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

About AGAE Allied Gaming & Entertainment Inc.

Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.

Share on Social Networks: